Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrijana Radivojevic

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|July 25, 2014
Enhancing population pharmacokinetic modeling efficiency and quality using an integrated workflowHenning Schmidt, Andrijana Radivojevic
CPT: Pharmacometrics & Systems Pharmacology|August 18, 2023
Improving pharmacometrics analysis efficiency using DataCheQC: An interactive, Shiny-based app for quality control of pharmacometrics datasetsOr Dotan, Andrijana Radivojevic, Rajendra Singh
Pharmaceutics|June 2, 2021
Scaling Approaches for Pediatric Dose Selection: The Fremanezumab (AJOVY<sup>®</sup>) Journey to Select a Phase 3 Dose Using Pharmacokinetic Data from a Phase 1 StudyAksana Jones, Orit Cohen-Barak, Andrijana Radivojevic, et al.
BMC Infectious Diseases|December 19, 2024
Replacing serum with dried blood microsampling for pharmacokinetics, viral neutralisation and immunogenicity bioanalysis supporting future paediatric development of RSM01, a candidate respiratory syncytial virus neutralising monoclonal antibodyJoleen T White, Jonne Terstappen, Micha Levi, et al.
BMC Infectious Diseases|December 3, 2024
RSM01, a novel respiratory syncytial virus monoclonal antibody: preclinical characterization and results of a first-in-human, randomised clinical trialAurelio Bonavia, Micha Levi, Harald Rouha, et al.
Cephalalgia : an International Journal of Headache|May 18, 2021
Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approachOrit Cohen-Barak, Andrijana Radivojevic, Aksana Jones, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Pharmacokinetics and Pharmacodynamics|July 25, 2014
Enhancing population pharmacokinetic modeling efficiency and quality using an integrated workflowHenning Schmidt, Andrijana Radivojevic
CPT: Pharmacometrics & Systems Pharmacology|August 18, 2023
Improving pharmacometrics analysis efficiency using DataCheQC: An interactive, Shiny-based app for quality control of pharmacometrics datasetsOr Dotan, Andrijana Radivojevic, Rajendra Singh
Pharmaceutics|June 2, 2021
Scaling Approaches for Pediatric Dose Selection: The Fremanezumab (AJOVY<sup>®</sup>) Journey to Select a Phase 3 Dose Using Pharmacokinetic Data from a Phase 1 StudyAksana Jones, Orit Cohen-Barak, Andrijana Radivojevic, et al.
BMC Infectious Diseases|December 19, 2024
Replacing serum with dried blood microsampling for pharmacokinetics, viral neutralisation and immunogenicity bioanalysis supporting future paediatric development of RSM01, a candidate respiratory syncytial virus neutralising monoclonal antibodyJoleen T White, Jonne Terstappen, Micha Levi, et al.
BMC Infectious Diseases|December 3, 2024
RSM01, a novel respiratory syncytial virus monoclonal antibody: preclinical characterization and results of a first-in-human, randomised clinical trialAurelio Bonavia, Micha Levi, Harald Rouha, et al.
Cephalalgia : an International Journal of Headache|May 18, 2021
Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approachOrit Cohen-Barak, Andrijana Radivojevic, Aksana Jones, et al.
Pageof 1